Cited by 145Gestational Diabetes Research and ManagementFatty Acid Research and HealthProbiotics and Fermented Foods

Efficacy of Fish Oil and/or Probiotic Intervention on the Incidence of Gestational Diabetes Mellitus in an At-Risk Group of Overweight and Obese Women: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Pellonperä, Outi, Mokkala, Kati, Houttu, Noora, Vahlberg, Tero, Koivuniemi, Ella, Tertti, Kristiina, Rönnemaa, Tapani, Laitinen, Kirsi·2019·Diabetes Care

Abstract

OBJECTIVE: To assess whether the risk of gestational diabetes mellitus (GDM) may be lowered and glucose metabolism improved by daily administration of fish oil and/or probiotic supplements in overweight and obese pregnant women. RESEARCH DESIGN AND METHODS: We randomized in a double-blind manner 439 women (mean 13.9 ± 2.1 gestational weeks [gw]) into four intervention groups: fish oil + placebo, probiotics + placebo, fish oil + probiotics, and placebo + placebo. Fish oil (1.9 g docosahexaenoic acid and 0.22 g eicosapentaenoic acid) and probiotic supplements (Lactobacillus rhamnosus HN001 and Bifidobacterium animalis ssp. lactis 420, 1010 colony-forming units each) were provided for daily consumption from randomization beyond delivery. Primary outcomes were the incidence of GDM diagnosed with oral glucose tolerance test targeted at 24–28 gw and the change in fasting glucose between randomization and late pregnancy (mean 35.2 ± 0.9 gw). Insulin concentration, insulin resistance HOMA2-IR index, and pregnancy outcomes were determined, as were adverse effects related to the intervention. Analyses were by intent to treat. RESULTS: No differences were found among the intervention groups in the maternal and neonatal pregnancy outcomes or side effects related to the intervention (P > 0.05). The proportion of women with GDM (94 of 377; fish oil + placebo, 23 of 96, 24.0%; probiotics + placebo, 25 of 99, 25.3%; fish oil + probiotics, 26 of 91, 28.6%; and placebo + placebo, 20 of 91, 22.0%) and the change in glucose, insulin, or HOMA2-IR (n = 364) did not differ among the intervention groups (P > 0.11 for all comparisons). CONCLUSIONS: An intervention with fish oil and/or probiotics during pregnancy seemed to be both safe and well tolerated but conferred no benefits in lowering the risk of GDM or improving glucose metabolism in overweight and obese women.

Integrity signals

Registry

Crossref · 10.2337/dc18-2591

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies on the beneficial effects of probiotics in the prevention or treatment of GDM have inconclusive results.

    “However, in the conducted studies on the beneficial effects of probiotics in the prevention or treatment of GDM, the results are still inconclusive [88,89,90,91].”

    From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [88]

Cites

Flagged first, then by citations

2 of the 42 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Pellonperä, O., Mokkala, K., Houttu, N., Vahlberg, T., Koivuniemi, E., Tertti, K., Rönnemaa, T., & Laitinen, K.
Affiliations
University of Turku (FI)
Corresponding author
Pellonperä, Outi
Venue
Diabetes Care
Published
2019-04-09
Volume
42
Issue
6
Pages
1009-1017
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2938463432
Cited by
145
References
42
Citations by year
2026: 13 · 2025: 23 · 2024: 21 · 2023: 14 · 2022: 33 · 2021: 22 · 2020: 15 · 2019: 4
FWCI
20.15
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Academy of Finland (258606)
  • state research funding for university-level health research of the Turku University Hospital Expert Responsibility Area
  • Diabetes Research Foundation
  • Juho Vainio Foundation
  • Business Finland (3486/31/2015)
  • The Finnish Medical Foundation
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
gestational diabetes mellitus, fish oil supplementation, probiotics, docosahexaenoic acid, eicosapentaenoic acid, Lactobacillus rhamnosus HN001, Bifidobacterium animalis subsp. lactis, overweight in pregnancy, maternal obesity, glucose metabolism, insulin resistance, HOMA2-IR, fasting blood glucose, pregnancy outcomes, neonatal outcomes
MeSH terms
Adult, Double-Blind Method, Female, Fish Oils, Glucose Tolerance Test, Humans, Insulin Resistance, Obesity, Placebos, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Risk Factors, Incidence, Diabetes, Gestational, Treatment Outcome, Dietary Supplements, Probiotics, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review